P. Lipari

发表

Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice

Walter A. Korfmacher, W. R. Bishop, Jianping Chen, 1999, Cancer Chemotherapy and Pharmacology.

Toxin-Mediated Paracellular Transport of Antitoxin Antibodies Facilitates Protection against Clostridium difficile Infection

A. Therien, L. Hernandez, X. Chen, 2014, Infection and Immunity.

Fluorescence polarization assay and inhibitor design for MDM2/p53 interaction.

Yaolin Wang, J. Gesell, Yaolin Wang, 2004, Analytical biochemistry.

Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer

L. Nielsen, B. Shi, J. Dell, 1999, Cancer Chemotherapy and Pharmacology.

Adenovirus-mediated p 53 Gene Therapy and Paclitaxel Have Synergistic Efficacy in Models of Human Head and Neck , Ovarian , Prostate , and Breast Cancer

L. Nielsen, J. Dell, P. Lipari, 2005 .

Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.

L. Nielsen, G. Hajian, L L Nielsen, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice.

Walter A. Korfmacher, W. R. Bishop, J. Catino, 1998, Cancer research.

Inhibitors of farnesyl protein transferase. 4-Amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazine.

Walter A. Korfmacher, W. R. Bishop, J. Chen, 1998, Journal of medicinal chemistry.

Structure-activity relationship of 3-substituted N-(pyridinylacetyl)-4- (8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene )- piperidine inhibitors of farnesyl-protein transferase: design and synthesis of in vivo active antitumor compounds.

W. R. Bishop, J. Catino, M. Malkowski, 1997, Journal of medicinal chemistry.

Combination therapy with the farnesyl protein transferase inhibitor SCH66336 and SCH58500 (p53 adenovirus) in preclinical cancer models.

W. R. Bishop, Meilin Liu, L. Nielsen, 1999, Cancer research.

Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti–IGF-IR antibody

W. R. Bishop, L. Presta, Yaolin Wang, 2005, Molecular Cancer Therapeutics.

A Fully Human Insulin-Like Growth Factor-I Receptor Antibody SCH 717454 (Robatumumab) Has Antitumor Activity as a Single Agent and in Combination with Cytotoxics in Pediatric Tumor Xenografts

W. R. Bishop, Yaolin Wang, Xiaoying Wang, 2010, Molecular Cancer Therapeutics.

Kibdelomycin Is a Potent and Selective Agent against Toxigenic Clostridium difficile

D. Gerding, D. Hecht, D. Olsen, 2014, Antimicrobial Agents and Chemotherapy.

Discovery of Novel 3,3-Disubstituted Piperidines as Orally Bioavailable, Potent, and Efficacious HDM2-p53 Inhibitors.

W. R. Bishop, D. Hicklin, G. Scapin, 2016, ACS medicinal chemistry letters.

Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti–IGF-IR antibody

L. Presta, Yaolin Wang, Yan Wang, 2005, Molecular Cancer Therapeutics.